Literature DB >> 17579212

Subcellular localization modulates activation function 1 domain phosphorylation in the androgen receptor.

Cristina T Kesler1, Daniel Gioeli, Mark R Conaway, Michael J Weber, Bryce M Paschal.   

Abstract

Although the steady-state distribution of the androgen receptor (AR) is predominantly nuclear in androgen-treated cells, androgen-bound AR shuttles between the nucleus and the cytoplasm. In the present study we have addressed how nucleocytoplasmic shuttling contributes to the regulation of AR. Nuclear transport signal fusions were used to force AR localization to the nucleus or cytoplasm of prostate cancer cells, and the effect of localization on shuttling, transcription, androgen binding, and phosphorylation was determined. Fusing the simian virus 40 nuclear localization signal or c-Abl nuclear export signal to AR resulted in androgen-independent localization to the nucleus or cytoplasm, respectively. AR forced to the nucleus was transcriptionally active on prostate-specific antigen and mouse mammary tumor virus promoters driving reporter genes. AR forced to the cytoplasm was largely inactive on the prostate-specific antigen promoter, but, surprisingly, AR was active on the mouse mammary tumor virus promoter and on two endogenous genes examined. Thus, highly transient nuclear localization of AR is sufficient to activate transcription. Androgen dissociation rates and the dissociation constant (K(D)) of AR for androgen were similar whether AR was localized to the cytoplasm or the nucleus, suggesting the ligand-binding cycle of AR is not strictly linked to its compartmentalization. Using phosphosite antibodies, we found that compartmentalization influences the phosphorylation state of AR. We show there is a bias for androgen-dependent phosphorylation of Ser81, Ser256, and Ser308 in the nucleus and androgen-independent phosphorylation of Ser94 in the cytoplasm. We propose that one function of nucleocytoplasmic shuttling is to integrate the signaling environment in the cytoplasm with AR activity in the nucleus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17579212     DOI: 10.1210/me.2007-0240

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  16 in total

1.  Inhibition of IGF-1R diminishes transcriptional activity of the androgen receptor and its constitutively active, C-terminally truncated counterparts Q640X and AR-V7.

Authors:  Friedemann Zengerling; Anca Azoitei; Alexander Herweg; Florian Jentzmik; Marcus V Cronauer
Journal:  World J Urol       Date:  2015-08-29       Impact factor: 4.226

2.  Activation of the DNA-dependent protein kinase stimulates nuclear export of the androgen receptor in vitro.

Authors:  Leonard C Shank; Joshua B Kelley; Daniel Gioeli; Chun-Song Yang; Adam Spencer; Lizabeth A Allison; Bryce M Paschal
Journal:  J Biol Chem       Date:  2008-02-12       Impact factor: 5.157

3.  Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer.

Authors:  Joshua W Russo; Xiaming Liu; Huihui Ye; Carla Calagua; Sen Chen; Olga Voznesensky; James Condulis; Fen Ma; Mary-Ellen Taplin; David J Einstein; Steven P Balk; Shaoyong Chen
Journal:  Cancer Lett       Date:  2018-09-11       Impact factor: 8.679

4.  Effect of anabolic-androgenic steroids and glucocorticoids on the kinetics of hAR and hGR nucleocytoplasmic translocation.

Authors:  Amy B Cadwallader; Douglas E Rollins; Carol S Lim
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

5.  Androgen receptor serine 81 mediates Pin1 interaction and activity.

Authors:  Raffaele La Montagna; Isabella Caligiuri; Pasquale Maranta; Chiara Lucchetti; Luca Esposito; Marco G Paggi; Giuseppe Toffoli; Flavio Rizzolio; Antonio Giordano
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

6.  Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5.

Authors:  Fu-Ning Hsu; Mei-Chih Chen; Ming-Ching Chiang; Eugene Lin; Yueh-Tsung Lee; Pao-Hsuan Huang; Guan-Shun Lee; Ho Lin
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

7.  Identification of androgen receptor phosphorylation in the primate ovary in vivo.

Authors:  Iain J McEwan; Dagmara McGuinness; Colin W Hay; Robert P Millar; Philippa T K Saunders; Hamish M Fraser
Journal:  Reproduction       Date:  2010-04-20       Impact factor: 3.906

8.  Androgen induces a switch from cytoplasmic retention to nuclear import of the androgen receptor.

Authors:  Li Ni; Ryan Llewellyn; Cristina T Kesler; Joshua B Kelley; Adam Spencer; Chelsi J Snow; Leonard Shank; Bryce M Paschal
Journal:  Mol Cell Biol       Date:  2013-10-07       Impact factor: 4.272

9.  SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.

Authors:  Sanna Kaikkonen; Tiina Jääskeläinen; Ulla Karvonen; Miia M Rytinki; Harri Makkonen; Daniel Gioeli; Bryce M Paschal; Jorma J Palvimo
Journal:  Mol Endocrinol       Date:  2008-12-30

10.  FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells.

Authors:  Li Ni; Chun-Song Yang; Daniel Gioeli; Henry Frierson; David O Toft; Bryce M Paschal
Journal:  Mol Cell Biol       Date:  2010-01-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.